Cushing's syndrome

(redirected from Cushing's)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to Cushing's: Cushing's syndrome, Cushing's disease, Cushing's ulcer, Cushing's triad, Addison's

Cushing's syndrome

[′ku̇sh·iŋz ‚sin‚drōm]
(medicine)
A complex of symptoms including facial and truncal obesity, hypertension, edema, and osteoporosis, resulting from oversecretion of adrenocortical hormones.
References in periodicals archive ?
She was diagnosed with Cushing's syndrome secondary to an adrenal adenoma.
Cushing's disease most commonly affects adults as young as 20 to 50 years and affects women three times more often than men.
It is especially appropriate that we are making this announcement just before Cushing's Awareness Day, which will be observed on Sunday," noted NORD President and CEO Peter L.
Feingold said "This is a tremendous honor made possible by a group of devoted citizens with immense pride in Alonzo Cushing's actions and Wisconsin history.
While she does not support Cushing's "political position" regarding the apology, Wilde said, "I do support him very much as a priest and a friend, and I think Fr.
Cushing's deep admiration and respect for his mentor and friend would culminate in a biography of Osler, titled The Life of Sir William Osler, which won the 1926 Pulitzer Prize.
Most cases of Cushing's syndrome are caused by benign, or noncancerous tumors of the pituitary gland called adenomas, which secrete increased amounts of ACTH.
A snapshot of the global therapeutic scenario for Cushing's Syndrome.
Most importantly, the report provides valuable insights on the pipeline products within the global Cushing's Syndrome Therapeutics sector.
The Trojans use Cushing as a defensive end, which means some might view it as a 3-4 defense with an extra linebacker, even though Cushing's role is similar to that of a defensive end.
Teresa of Avila Parish, has asked Cushing to leave at the end of the month because coverage of Cushing's pilgrimage in the diocesan paper and The Augusta Chronicle caused an outcry, including numerous letters to the editor to the Chronicle criticizing Cushing.
Nasdaq: DAHI; Toronto) announced today that it has filed its first regulatory application ("New Drug Submission") with the Canadian Health Protection Branch, Bureau of Veterinary Drugs (HPB/BVD), seeking approval to market Anipryl(R) (I-deprenyl, selegiline hydrochloride) for the treatment of canine Cushing's disease.